CBD and hypertension and the heart: what do studies say and is it safe?

Hypertension affects over 10 million Poles and is one of the main risk factors for heart attack and stroke. In this context, CBD, which is gaining popularity as a stress-reducing supplement, raises the natural question: can it affect blood pressure? The answer is complex: a clinical study from 2017 showed a clear hypotensive effect, but there are several "buts" — regarding dosage, mechanism, drug interactions, and safety in individuals with heart conditions. This article goes through the data without oversimplifying.

KEY INFORMATION
• Jadoon et al. (JCI Insight, 2017) demonstrated that 600 mg of CBD reduced systolic blood pressure by 6 mmHg at rest and 5 mmHg under stress — a statistically significant effect.
• CBD may interact with antihypertensive medications by inhibiting CYP3A4 and CYP2C9 — a cardiology consultation is necessary.
• Individuals with arrhythmia, atrial fibrillation, or those taking warfarin require special caution.
• WHO (2018) recognizes CBD as a safe substance, but not clinically studied as an antihypertensive drug — it does not replace pharmacotherapy for hypertension.

Key study: Jadoon et al. 2017 – what was really shown?

Study Jadoon et al. published in JCI Insight (2017) is the most important clinical study regarding CBD and the cardiovascular system. It was a randomized, crossover trial with a double-blind design: 9 healthy volunteers received a single dose of 600 mg of CBD or placebo in two sessions with a one-week break.

Results: CBD significantly reduced resting systolic blood pressure (by an average of 6 mmHg) and decreased the rise in blood pressure in response to stress (a difference of 5 mmHg vs placebo). A trend towards a decrease in resting heart rate was also observed, although this difference did not reach statistical significance. The authors summarized that CBD has a "beneficial effect on the cardiovascular system" and suggested that the effect may be partially mediated by its anxiolytic properties — stress reduction translates into less activation of the sympathetic nervous system and lower blood pressure.

The limitations of the study are significant: very small sample size (9 individuals), single dose (600 mg — multiple times higher than typical supplemental doses), exclusively healthy men (without hypertension), short observation period. We do not know how CBD affects blood pressure with multi-week use or in individuals actually with hypertension. Extrapolating these results to "CBD cures hypertension" would be a significant overreach — but the biological effect is documented and requires further research.

How CBD may affect the cardiovascular system – biological mechanisms

The hypotensive effect of CBD has several potential mechanisms that have been described in preclinical and laboratory studies. The first is vasodilation — CBD causes the dilation of blood vessels by activating TRPV1 receptors and TRP channels in the vascular endothelium, which reduces peripheral resistance and lowers blood pressure. Another is the anxiolytic effect — reducing stress and anxiety decreases activation of the HPA axis and the sympathetic nervous system, which secondarily lowers blood pressure.

The third mechanism is the modulation of CB1 receptors in the heart and blood vessels — the endocannabinoid system regulates vascular tone, and CBD indirectly influences this pathway by inhibiting the breakdown of anandamide. Finally, CBD has cardioprotective properties described in animal models: Durst et al. (Journal of Pharmacology and Experimental Therapeutics, 2007) demonstrated that CBD reduced the size of the infarct and myocardial dysfunction in mice after experimental ischemia, through antioxidant and anti-inflammatory mechanisms. Although these data are only from animal studies, they suggest a broader cardioprotective potential of CBD.

Interactions with cardiovascular medications – CYP3A4 and key risk groups

This is the most important aspect of the article for individuals undergoing cardiology pharmacotherapy. CBD inhibits the enzymes CYP3A4 and CYP2C9 in the liver — these enzymes are responsible for the metabolism of many medications. When CBD blocks these enzymes, the concentration of concurrently taken medication may rise to toxic levels or the therapeutic effect may be uncontrollably enhanced.

Statins (atorvastatin, simvastatin, lovastatin) are primarily metabolized by CYP3A4. Combining CBD with statins may increase the concentration of statin in the blood, which carries the risk of myopathy (muscle weakness and pain) or rarely rhabdomyolysis. Supplemental doses of CBD (up to 30 mg) likely have minimal clinical impact, but higher doses or premedication with CBD before a statin dose requires monitoring.

Beta-blockers (metoprolol, bisoprolol, propranolol) are partially metabolized by CYP2D6 and CYP2C19. CBD may inhibit these enzymes, potentially increasing the concentration of beta-blockers and intensifying their bradycardic and hypotensive effect. The combination of CBD + beta-blocker without cardiology supervision may lead to unexpected episodes of bradycardia or orthostatic hypotension.

Warfarin and DOAC (dabigatran, rivaroxaban) — a particularly risky combination. CBD may enhance the effect of warfarin by inhibiting CYP2C9, which increases INR and the risk of bleeding. This is not a hypothetical interaction — case reports describe clinically significant increases in INR in patients taking warfarin and CBD. If you are taking any anticoagulants — consulting a doctor before using CBD is essential.

Important practical principle: The effect of CBD on CYP inhibition strongly depends on the dose. Supplementary doses of 10–30 mg of CBD have a significantly smaller impact on CYP enzymes than therapeutic doses of 300–600 mg. However, this does not mean that small doses are always safe with all cardiovascular medications — interactions are individual and depend on the specific drug, its therapeutic window, and the enzymatic activity of the individual.

Arrhythmia and atrial fibrillation – special caution

Individuals with heart arrhythmias, including atrial fibrillation (AF) or tachycardia, should exercise particular caution when using CBD. Although CBD is not a documented proarrhythmic drug, several aspects require attention.

Antiarrhythmic drugs (amiodarone, flecainide, propafenone) are strong substrates of CYP3A4 and CYP2D6 — exactly the enzymes that CBD may inhibit. An increase in the concentration of the antiarrhythmic drug may paradoxically lead to proarrhythmia. Amiodarone has a particularly narrow therapeutic window and a very long half-life — interactions with it can have consequences even weeks after discontinuing CBD or the drug.

Atrial fibrillation itself is an indication for anticoagulation (warfarin or DOAC) — which brings us back to the point about the risk of interactions with anticoagulant medications. There is no safe protocol for using CBD in a patient with atrial fibrillation without consulting a cardiologist. Information about CBD and drug interactions can also be found in the article on CBD for seniors, where drug interactions are discussed in detail: CBD for seniors – drug interactions.

Hypertension and lifestyle – the role of CBD in a comprehensive approach

Hypertension is a condition where lifestyle modifications have documented effectiveness — a reduction in pressure of 5–10 mmHg is achievable solely through dietary changes and physical activity. The DASH diet (rich in vegetables, fruits, low-fat dairy products, low in sodium) lowers systolic pressure by 8–14 mmHg, and regular aerobic exercise (30 minutes a day for 5 days a week) by 4–9 mmHg. Weight reduction yields similar effects.

In this context, CBD — with a hypotensive effect of 5–6 mmHg observed by Jadoon et al. — fits as a potentially complementary element of lifestyle modifications. Particularly in individuals with stress-dependent hypertension (pressure spikes mainly in stressful situations but returns to normal at rest), the anxiolytic effect of CBD may have clinically significant implications for daily blood pressure values. Reducing chronic stress is one of the most important non-pharmacological modifications in hypertension.

Monitoring home blood pressure while using CBD makes sense especially for individuals with borderline pressure (130–139/80–89 mmHg) — it can be assessed whether CBD as part of lifestyle changes affects measurements. A wrist or arm blood pressure monitor with memory will allow tracking trends. If blood pressure clearly drops after introducing CBD (by more than 5–8 mmHg in home measurements) — this is information to share with a doctor, not a reason to independently discontinue antihypertensive medications.

What do we know about the long-term use of CBD by individuals with cardiovascular diseases?

Long-term studies are a weak point in the literature regarding CBD in cardiovascular diseases. The study by Jadoon et al. (2017) was a one-time, short-term study on a small group. We do not have good data from multi-month randomized trials on populations with hypertension or post-myocardial infarction.

What we have are observational data. A broad meta-analysis of the safety of CBD conducted by WHO (2018) did not show cardiovascular signals with regular use of CBD in supplementary doses. Reports from clinical trials on Epidiolex (CBD in epilepsy), where high doses of 10–20 mg/kg/day were used, showed sporadic cases of bradycardia and hypotension — but at doses several dozen times higher than typical supplements.

At supplementary doses of CBD (up to 50 mg/day) in individuals without serious heart diseases and without pharmacological treatment, the risk of cardiovascular events is likely very low. With active pharmacotherapy — the risk of interactions is real and requires supervision. In summary: there is no evidence of harm from supplementary doses of CBD for the heart in healthy individuals; caution and monitoring are necessary for those with active cardiovascular pathology or pharmacotherapy.

CBD and cholesterol and vascular inflammation – what do preclinical studies say?

Cardiovascular diseases have a strong inflammatory component — chronic endothelial inflammation, oxidized LDL, and platelet aggregation play a key role in the pathogenesis of atherosclerosis. CBD has described anti-inflammatory and antioxidant properties, which theoretically could have cardioprotective significance.

Preclinical animal studies suggest that CBD may reduce the expression of adhesion molecules (ICAM-1, VCAM-1) on the vascular endothelium — which is an early step in the pathogenesis of atherosclerosis. Rajesh et al. (Journal of Cardiovascular Pharmacology, 2009) demonstrated in a model of diabetic cardiomyopathy that CBD reduced oxidative stress in cardiac muscle, reduced fibrosis, and improved contractile function. These are fascinating results — but exclusively animal-based. We do not have data from clinical studies in humans confirming a similar effect on cholesterol or atherosclerosis. CBD is not a drug for atherosclerosis — it is a substance with interesting biological properties that await confirmation in solid clinical studies.

Can CBD replace antihypertensive medications?

No. This is a clear answer that does not require lengthy justification. Hypertension is a condition that requires clinically documented pharmacological treatment — not because medications are always pleasant to use, but because untreated hypertension dramatically increases the risk of heart attack, stroke, kidney failure, and retinopathy. Antihypertensive medications (ACE inhibitors, ARBs, beta-blockers, diuretics) have decades of clinical research and hard data on reducing cardiovascular mortality. CBD does not have such a data set.

What CBD can do in the context of hypertension as a supplement: it may support stress reduction, which is one of the factors raising blood pressure; it may improve sleep quality, which translates into better control of nighttime pressure; it may potentially support the hypotensive effect in stress-dependent hypertension when used together with medications (after consulting a doctor). These are valuable supportive roles — but they do not replace the primary pharmacotherapy for hypertension. Any change in the hypertension treatment plan requires supervision from a cardiologist or internist.

If you are considering CBD as an element of stress management that enhances blood pressure control, you may find useful tips in the article on the practical use of CBD for stress: CBD for work stress. Occupational stress is one of the main environmental risk factors for hypertension, especially for individuals working at a computer for more than 8 hours a day. Managing this stress — whether with the help of CBD, breathing techniques, psychotherapy, or changing work habits — is part of the cardiological approach to hypertension.

Summary – for whom does CBD make sense for heart issues, and for whom does it not?

Healthy adults with borderline blood pressure and stress-related hypertension, without cardiovascular pharmacotherapy, may consider CBD as one of the elements of lifestyle modification — after informing their doctor. This is the most sensible application of the available knowledge. Individuals with established hypertension requiring pharmacological treatment should consult a cardiologist or internist before incorporating CBD — mainly due to the risk of drug interactions. Those with arrhythmia, atrial fibrillation, a history of heart attack, or severe heart failure should use CBD only under medical supervision. Benefits may exist, but the risk of interactions is real.

Frequently Asked Questions

Does CBD lower blood pressure?

Jadoon et al. (JCI Insight, 2017) demonstrated that a single dose of 600 mg of CBD reduced systolic blood pressure by an average of 6 mmHg at rest and by 5 mmHg in response to stress. The effect is statistically significant, but the study concerned a single dose in healthy individuals — data on long-term use in actual hypertension is limited.

Can CBD be taken with blood pressure medications?

CBD may interact with many antihypertensive medications and statins by inhibiting CYP3A4 and CYP2C9. Combining it without cardiological consultation is risky due to the potential summation of hypotensive effects and unexpected changes in drug concentrations. Always consult with a cardiologist or internist before incorporating CBD.

Is CBD safe for heart diseases?

WHO (2018) considers CBD generally safe; however, individuals with arrhythmia, atrial fibrillation, or those taking warfarin require special caution due to drug interactions. A cardiological consultation is mandatory before using CBD with active heart disease.

How much CBD should be taken for hypertension?

There is no clinical dosage recommendation for CBD for hypertension — the Jadoon study used 600 mg, which is a therapeutic dose. With supplemental use (10–30 mg/day), the effect on blood pressure will be smaller. Do not replace antihypertensive medications with CBD without medical supervision.

Does CBD affect heart function (heart rate)?

The Jadoon study observed a trend towards a reduction in resting heart rate after CBD, but the effect was not statistically significant. At supplemental doses of CBD (10–30 mg), the impact on heart rate in healthy individuals is minimal. With antiarrhythmic medications — caution is advised due to possible metabolic interactions.

This article is for informational and educational purposes and does not constitute medical advice. Before starting to use cannabis or CBD for therapeutic purposes, consult your doctor, especially if you are taking other medications, are pregnant, or breastfeeding.

Author: Michał Waluk · Published: 2026-05-04 · Updated: 2026-05-04